Protein-rich foods and certain bioactive compounds may increase postprandial GLP-1 secretion, though effects are modest compared to pharmaceutical GLP-1 agonists
These facilities are required to maintain full compliance with current good manufacturing practices (cGMP), the same cGMP standards to which generic and brand-name medications are held. A recent article compared the safety reports from adverse events from brand-name medication vs
LMNs are documents written by healthcare providers justifying the necessity of a medication or treatment
However, a 57% reduction in renal events was observed compared to those receiving only GLP-1 RAs ( In 2024, Ahmad and Sabbour conducted a meta-analysis encompassing data from over 110,000 patients, encompassing 13 investigations that evaluated the combined use of GLP-1 RAs and SGLT-2 inhibitors
Coordinated care between providers manages these transitions safely
68,69,70 Recent studies have explored the molecular mechanisms underlying the phenomenon of cell fate conversion by combining scRNA-seq and dual recombinase-mediated lineage tracing